Gillian Hanley
Has grant
Assistant Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Gillian Hanley is an Assistant Professor at the University of British Columbia, Canada. Her research focuses on women's health issues, particularly in relation to cancer outcomes and mental health. Recent articles include studies on prenatal antidepressant use, the impact of early age-onset colorectal cancer in females, and ovarian cancer risks. Dr. Hanley is committed to advancing understanding of sexual health and patient engagement in cancer research.
Recent Grants
Grant: Close
Postpartum domperidone use to stimulate breast milk supply: do maternal and infant health benefits outweigh potential harm? A systematic review
Open Date: 2015-06-01
Close Date: 2016-05-31
Grant: Close
A population-based assessment of an ovarian cancer prevention program
Open Date: 2014-08-01
Close Date: 2017-07-31
Grant: Close
Developmental origins of autism: A population level linked data study of prenatal antidepressant medication exposure
Open Date: 2014-04-01
Close Date: 2017-03-31
Grant: Close
Psychotropic drug use in pregnancy: patterns of use and neonatal and infant health outcomes
Open Date: 2012-03-01
Close Date: 2013-02-28
Grant: Close
Socioeconomic status as a predictor of prenatal mental health, use of selective serotonin reuptake inhibitors during pregnancy, and infant outcomes
Open Date: 2011-09-01
Close Date: 2014-08-31
Articles (24)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Over the last two decades, patient engagement in cancer research has evolved significantly, especially in addressing the unique challenges faced by adolescent and young adult (AYA) cancer populations. This paper introduces a framework for meaningful engagement with AYA cancer patient research partners, drawing insights from the “FUTURE” Study, a qualitative study that utilizes focus groups to explore the impact of cancer diagnosis and treatment on the sexual and reproductive health of AYA cancer patients in Canada. The framework’s development integrates insights from prior works and addresses challenges with patient engagement in research specific to AYA cancer populations. The framework is guided by overarching principles (safety, flexibility, and sensitivity) and includes considerations that apply across all phases of a research study (collaboration; iteration; communication; and equity, diversity, and inclusion) and tasks that apply to specific phases of a research study (developing, conducting, and translating the study). The proposed framework seeks to increase patient engagement in AYA cancer research beyond a supplementary aspect to an integral component for conducting research with impact on patients.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Collaborators (14)
Nora Pashayan
Professor of Applied Cancer Research
University College London
Britton Trabert
Associate Professor
University of Utah
Vienna Cheng
The University of British Columbia
Lori Brotto
Associate Professor
The University of British Columbia
Bruce A. Vallance
-
Mary A. De Vera
The University of British Columbia
Lesa Dawson
Associate Professor
Memorial University of Newfoundland
Rafael Meza
Professor
University of Michigan
Alice Lee
Associate Professor
California State University Fullerton
Hoda Anton-Culver
University of California, Irvine
Kasmintan Schrader
The University of British Columbia
Fuchsia Howard
Associate Professor
The University of British Columbia
Amirrtha Srikanthan
University of Ottawa
Stuart Peacock
Professor
Simon Fraser University
Make your next move.
Prepare your application
Review drafts before you send them.